Bulk XCE Tirzepatide CAS 2023788-19-2 White Powder - Custom Orders Available

XCE tirzepatide is a high-purity peptide powder developed for research applications, particularly in the study of type 2 diabetes and weight management. This product features a molecular formula of C225H348N48O68 and appears as a white powder with a purity level of 99.9%. It is supplied in vials of 10mg or 30mg, packaged securely in boxes of 10 vials each.

As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, XCE tirzepatide demonstrates enhanced efficacy in glucose control and weight reduction compared to selective GLP-1 agonists. Its mechanism involves mimicking natural GIP actions at receptors, contributing to significant hyperglycemia reduction. Research indicates that XCE tirzepatide can aid in weight loss, with clinical trials showing average reductions of 15-20.9% over 72 weeks depending on dosage.

XCE tirzepatide is modified with a PEG group on the lys side chain, enhancing water solubility and stability. This modification supports its functionality as a research compound in various experimental settings. It is important to note that this product is strictly for research use and not intended for personal consumption.

Storage guidelines for XCE tirzepatide include keeping the peptide in a cold, dry, and dark environment to maintain integrity. Avoid repeated freezing and thawing, minimize air exposure, and protect from light. For long-term stability, it is recommended to aliquot the peptide according to specific experimental requirements and avoid storing it in solution for extended periods.

This product is available for bulk orders, with a minimum order quantity of 10 vials. Custom packaging and logo printing services are offered to meet diverse research needs. Competitive pricing is provided for wholesale and bulk purchases, ensuring cost-effectiveness for laboratories and institutions.

XCE tirzepatide has undergone phase 3 clinical trials for weight management applications, showing promising results in adults with obesity or weight-related health conditions. Its FDA Fast Track designation underscores its potential in advancing treatment options, though it remains exclusively for research purposes at this stage.

For researchers seeking a reliable supply of XCE tirzepatide, this product offers high quality, consistency, and support for various experimental protocols. Ensure proper handling and adherence to storage guidelines to maximize research outcomes.